Great Point Partners’s Zura Bio ZURA Stock Holding History

Great Point Partners’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.1M	Buy	4,215,930 +400,000	+10%	+$2.42M	5.77%	3
2025 Q4	$20M	Hold	3,815,930	–	–	6.48%	3
2025 Q3	$16.5M	Buy	3,815,930 +645,736	+20%	+$1.16M	6.81%	4
2025 Q2	$3.33M	Hold	3,170,194	–	–	2.16%	19
2025 Q1	$4.09M	Hold	3,170,194	–	–	2.17%	22
2024 Q4	$7.93M	Sell	3,170,194 -93,478	-3%	-$333K	3.73%	12
2024 Q3	$13.3M	Sell	3,263,672 -1,378,569	-30%	-$5.15M	3.9%	10
2024 Q2	$16.2M	Buy	4,642,241 +1,884,501	+68%	+$7.68M	3.11%	12
2024 Q1	$7.09M	Sell	2,757,740 -537,260	-16%	-$1.9M	1.1%	31
2023 Q4	$15.4M	Hold	3,295,000	–	–	2.62%	18
2023 Q3	$21.7M	Hold	3,295,000	–	–	3.96%	8
2023 Q2	$27M	Buy	+3,295,000	New	+$26.5M	5.29%	7

Other funds holding ZURA

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Great Point Partners's ZURA Position: Q1 2026 in Review

Great Point Partners increased its Zura Bio (ZURA) stake by 10% in Q1 2026, buying an estimated $2.42M and bringing the position to 4,215,930 shares worth $25.1M. The position accounts for 5.77% of the portfolio, ranked #3.

Great Point Partners first reported a position in ZURA in Q2 2023 and has held it in 12 quarters since. The position peaked at $27M in Q2 2023. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.

Great Point Partners held 4,215,930 shares of Zura Bio worth $25.1M as of Q1 2026.
Great Point Partners bought 400,000 Zura Bio shares in Q1 2026, an estimated $2.42M.
Zura Bio made up 5.77% of Great Point Partners's portfolio in Q1 2026, its #3 holding.
Great Point Partners first reported a position in Zura Bio in Q2 2023 and has held it in 12 quarters since.
Great Point Partners's Zura Bio position peaked at $27M in Q2 2023.
94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.

Based on Great Point Partners's 13F filing for Q1 2026, filed 15 May 2026.